These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36465073)

  • 21. Development of nitroalkene-based inhibitors to target STING-dependent inflammation.
    Chang F; Gunderstofte C; Colussi N; Pitts M; Salvatore SR; Thielke AL; Turell L; Alvarez B; Goldbach-Mansky R; Villacorta L; Holm CK; Schopfer FJ; Hansen AL
    Redox Biol; 2024 Aug; 74():103202. PubMed ID: 38865901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemia-induced STING signaling activation leads to aortic endothelial injury in diabetes.
    An Y; Geng K; Wang HY; Wan SR; Ma XM; Long Y; Xu Y; Jiang ZZ
    Cell Commun Signal; 2023 Dec; 21(1):365. PubMed ID: 38129863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STING signaling in inflammaging: a new target against musculoskeletal diseases.
    Song C; Hu Z; Xu D; Bian H; Lv J; Zhu X; Zhang Q; Su L; Yin H; Lu T; Li Y
    Front Immunol; 2023; 14():1227364. PubMed ID: 37492580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers.
    Cerro Chiang G; Parimon T
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex bias in systemic lupus erythematosus: a molecular insight.
    Bose M; Jefferies C
    Immunometabolism (Cobham); 2022 Jul; 4(3):e00004. PubMed ID: 35966636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cGAS-STING signalling in liver diseases.
    Chen R; Du J; Zhu H; Ling Q
    JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus.
    Hagiwara AM; Moore RE; Wallace DJ; Ishimori M; Jefferies CA
    Rheumatol Immunol Res; 2021 Sep; 2(3):173-184. PubMed ID: 36465073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.
    Kato Y; Park J; Takamatsu H; Konaka H; Aoki W; Aburaya S; Ueda M; Nishide M; Koyama S; Hayama Y; Kinehara Y; Hirano T; Shima Y; Narazaki M; Kumanogoh A
    Ann Rheum Dis; 2018 Oct; 77(10):1507-1515. PubMed ID: 29945921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes.
    Wang J; Dai M; Cui Y; Hou G; Deng J; Gao X; Liao Z; Liu Y; Meng Y; Wu L; Yao C; Wang Y; Qian J; Guo Q; Ding H; Qu B; Shen N
    Arthritis Rheumatol; 2018 Dec; 70(12):2036-2045. PubMed ID: 29806091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cyclic GMP-AMP synthase and Interferon-I-inducible protein 16 as candidatebiomarkers of systemic lupus erythematosus.
    Fu Q; He Q; Dong Q; Xie J; Geng Y; Han H; Huang Y; Lu J; Zeng Z; Wang W; Chen K; Zhan X
    Clin Chim Acta; 2022 Jan; 524():69-77. PubMed ID: 34742679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection.
    Hu Y; Chen B; Yang F; Su Y; Yang D; Yao Y; Wang S; Wu Y; Tao L; Xu T
    Autoimmun Rev; 2022 Sep; 21(9):103155. PubMed ID: 35902046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial Lon protease promotes CD4
    Huang X; Liu Y; Ling G; Cao X
    Int Immunopharmacol; 2023 Oct; 123():110519. PubMed ID: 37531828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COPA Syndrome (Ala239Pro) Presenting with Isolated Follicular Bronchiolitis in Early Childhood: Case Report.
    Psarianos P; Kwan JYY; Dell S; Wee WB; Rey-McIntyre K; Chen H; Dissanayake D; Laxer RM; Shum A; Liu FF; Yip KW
    J Clin Immunol; 2021 Oct; 41(7):1660-1663. PubMed ID: 34115278
    [No Abstract]   [Full Text] [Related]  

  • 34. Augmentation of Stimulator of Interferon Genes-Induced Type I Interferon Production in COPA Syndrome.
    Kato T; Yamamoto M; Honda Y; Orimo T; Sasaki I; Murakami K; Hemmi H; Fukuda-Ohta Y; Isono K; Takayama S; Nakamura H; Otsuki Y; Miyamoto T; Takita J; Yasumi T; Nishikomori R; Matsubayashi T; Izawa K; Kaisho T
    Arthritis Rheumatol; 2021 Nov; 73(11):2105-2115. PubMed ID: 33982886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TREX1 as a Novel Immunotherapeutic Target.
    Hemphill WO; Simpson SR; Liu M; Salsbury FR; Hollis T; Grayson JM; Perrino FW
    Front Immunol; 2021; 12():660184. PubMed ID: 33868310
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.